Log In
BCIQ
Print this Print this
 

SUBA-Itraconazole (Lonzanoc, SUBA Itraconazole, Subacap)

Also known as: Subazole

  Manage Alerts
Collapse Summary General Information
Company Mayne Pharma Group Ltd.
DescriptionOral capsule formulation of itraconazole, an azole antifungal agent and inhibitor of the hedgehog signaling pathway, using SUBA technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$15.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/25/2009

Undisclosed

$15.0M

Undisclosed

Get a free BioCentury trial today